IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA)
CUSIP: 462260100
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 395,322,451
- Total 13F shares
- 213,023,331
- Share change
- -7,201,156
- Total reported value
- $462,262,436
- Put/Call ratio
- 70%
- Price per share
- $2.17
- Number of holders
- 249
- Value change
- -$12,426,646
- Number of buys
- 119
- Number of sells
- 114
Quarterly Holders Quick Answers
What is CUSIP 462260100?
CUSIP 462260100 identifies IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 462260100:
Top shareholders of IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Wayne P. Rothbaum |
3/4/5
|
Director |
—
mixed-class rows
|
28,167,333
mixed-class rows
|
$257,731,097 | — | 01 Mar 2024 | |
| MHR FUND MANAGEMENT LLC |
13F
|
Company |
7.3%
|
28,967,103
|
$49,823,417 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
|
— |
3.8%
|
12,808,788
|
$45,599,285 | -$33,120,382 | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.3%
|
25,076,472
|
$43,131,531 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
6.4%
from 13D/G
|
23,236,812
|
$39,967,317 | — | 30 Jun 2025 | |
| Long Focus Capital Management, LLC |
13F
|
Company |
3%
|
11,820,000
|
$20,330,400 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
9,890,525
|
$17,011,703 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.4%
|
9,330,223
|
$16,047,984 | — | 30 Jun 2025 | |
| Invenomic Capital Management LP |
13F
|
Company |
2.1%
|
8,294,663
|
$14,266,820 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
6,450,933
|
$11,095,606 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
6,189,058
|
$10,645,836 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.2%
|
4,887,200
|
$8,405,984 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
4,749,876
|
$8,169,786 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.2%
|
4,633,451
|
$7,969,536 | — | 30 Jun 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
1.2%
|
4,601,441
|
$7,914,479 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1%
|
4,113,588
|
$7,075,371 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
4,029,568
|
$6,930,857 | — | 30 Jun 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
0.87%
|
3,429,329
|
$5,898,446 | — | 30 Jun 2025 | |
| Merrill A. Mcpeak |
3/4/5
|
Director |
—
mixed-class rows
|
618,783
mixed-class rows
|
$5,661,865 | — | 01 Mar 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.83%
|
3,261,707
|
$5,610,136 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.74%
|
2,928,736
|
$5,036,845 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.6%
|
2,379,088
|
$4,092,000 | — | 30 Jun 2025 | |
| Orion Investment Co |
13F
|
Company |
0.59%
|
2,338,563
|
$4,022,328 | — | 30 Jun 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.59%
|
2,334,900
|
$4,016,028 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.54%
|
2,119,787
|
$3,646,033 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.53%
|
2,114,190
|
$3,638,000 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.52%
|
2,071,472
|
$3,562,932 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.51%
|
2,007,571
|
$3,453,022 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.48%
|
1,916,486
|
$3,296,356 | — | 30 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.46%
|
1,800,000
|
$3,096,000 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.45%
|
1,779,412
|
$3,060,588 | — | 30 Jun 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.4%
|
1,591,575
|
$2,737,509 | — | 30 Jun 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.38%
|
1,507,782
|
$2,593,385 | — | 30 Jun 2025 | |
| B Group, Inc. |
13F
|
Company |
0.38%
|
1,500,000
|
$2,580,000 | — | 30 Jun 2025 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.32%
|
1,260,000
|
$2,167,000 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.31%
|
1,242,871
|
$2,137,738 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.27%
|
1,074,250
|
$1,847,711 | — | 30 Jun 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.23%
|
897,354
|
$1,543,449 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.22%
|
884,340
|
$1,521,065 | — | 30 Jun 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.22%
|
856,569
|
$1,473,299 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
780,627
|
$1,342,678 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.2%
|
778,750
|
$1,339,450 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.18%
|
714,851
|
$1,229,544 | — | 30 Jun 2025 | |
| CM Management, LLC |
13F
|
Company |
0.18%
|
700,000
|
$1,204,000 | — | 30 Jun 2025 | |
| QVT Financial LP |
13F
|
Company |
0.17%
|
678,564
|
$1,167,130 | — | 30 Jun 2025 | |
| Voss Capital, LP |
13F
|
Company |
0.17%
|
672,570
|
$1,156,820 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.17%
|
657,209
|
$1,130,400 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.17%
|
653,949
|
$1,124,792 | — | 30 Jun 2025 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.16%
|
647,827
|
$1,114,262 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.16%
|
620,446
|
$1,067,167 | — | 30 Jun 2025 |
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q3 2025
As of 30 Sep 2025,
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) was held by
249 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
213,023,331 shares.
The largest 10 holders included
MHR FUND MANAGEMENT LLC, BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Invenomic Capital Management LP, Long Focus Capital Management, LLC, Palo Alto Investors LP, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, and BANK OF AMERICA CORP /DE/.
This page lists
249
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
244
Q3 2025 holders
249
Holder diff
5
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.